In addition, Everolimus, an approved drug for partial seizures in children and adults with tuberous sclerosis, has been used with potential success in controlled clinical trials in treating individuals with PTEN-associated ASD and neurodevelopmental disorders [36,37]. Here, PTEN is linked to tuberous sclerosis.